Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
European Heart Journal|February 26, 2014
Effect of imatinib as add-on therapy on echocardiographic measures of right ventricular function in patients with significant pulmonary arterial hypertensionAmil M Shah, Patricia Campbell, Gabriela Querejeta Rocha, et al.
Journal of the American College of Cardiology|June 15, 2004
End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectivesMarius M Hoeper, Ronald J Oudiz, Andrew Peacock, et al.
Echocardiography (Mount Kisco, N.Y.)|September 23, 2014
Right heart and pulmonary vessels structure and functionMichele D'Alto, Giancarlo Scognamiglio, Kostantinos Dimopoulos, et al.
American Journal of Hematology|August 19, 2015
Clinical features of pulmonary arterial hypertension in patients receiving dasatinibNeil P Shah, Nicola Wallis, Harrison W Farber, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 7, 2023
Association between End-Stage Renal Disease and Major Adverse Limb Events after Peripheral Vascular InterventionYonatan Babore, Ansar Z Vance, Raphael Cohen, et al.
The European Respiratory Journal|January 28, 2012
Pregnancy outcomes in pulmonary arterial hypertension in the modern management eraXavier Jaïs, Karen M Olsson, Joan A Barbera, et al.
Cardiology and Therapy|January 28, 2024
Effect of Macitentan in Pulmonary Arterial Hypertension and the Relationship Between Echocardiography and cMRI Variables: REPAIR Echocardiography Sub-study ResultsAdam Torbicki, Richard Channick, Nazzareno Galiè, et al.
ERJ Open Research|February 13, 2024
Comparison of cardiac magnetic resonance imaging, functional and haemodynamic variables in pulmonary arterial hypertension: insights from REPAIRDavid G Kiely, Richard Channick, Dayana Flores, et al.
JACC. Cardiovascular Imaging|November 21, 2021
The REPAIR Study: Effects of Macitentan on RV Structure and Function in Pulmonary Arterial HypertensionAnton Vonk Noordegraaf, Richard Channick, Emmanuelle Cottreel, et al.
Biochemical and Biophysical Research Communications|July 9, 2014
Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertensionDongmin Shao, Frédéric Perros, Gaetano Caramori, et al.
Pageof 3